Aesthetic-clinic marketing in India sits in a strange middle ground. It is not full-scope medicine, but it is regulated as medical. It sells outcomes that are photogenic, but the outcomes ASCI and the CDSCO will actually let you photograph are a much narrower set. Founders keep asking why aesthetic and MedSpa growth on Instagram feels harder than it looks — usually the answer is that the compliance frame is upstream of the creative, and the operator running the account is treating it as downstream.
ICG runs aesthetic-clinic marketing engagements across MedSpas, injectables clinics, laser and body-contouring practices, and hair-restoration groups that sit alongside a broader aesthetic offer. This page is what we actually do — the playbook, the analytics stack, the compliance model, and the tier structure a clinic owner or chain operator will be signing off on if a scoped conversation goes ahead.
The aesthetic-clinic marketing playbook (India)
Aesthetic buyers in India are not researching the way IVF or cardiology buyers research. The consideration window is shorter, the search terms are more visual, the price sensitivity is real, and the decision is disproportionately influenced by the last two Reels the prospect scrolled past before they picked up the phone. This changes what a marketing programme has to look like at the top of the funnel.
Our aesthetic playbook is built around five moves that repeat every 90 days. First, the specialty coverage map — every service line the clinic actually delivers (injectables, laser hair reduction, HydraFacial, threads, body contouring, chemical peels, aesthetic dermatology, cosmetic gynaecology where applicable) gets its own creative track, its own landing surface, and its own Meta Ads set. Second, the outcome ladder — free consult → single-session trial → package → maintenance retainer — is mapped to a specific ad creative for each rung, not one generic offer. Third, the local footprint — a locked Google Business Profile programme powered by Angryturtle, ICG's own GBP OS, that runs reviews, categories, photos, Q&A and geo-grid rank tracking with actual publishing rights. Fourth, the doctor-personality layer — one clinician per specialty visibly running the Reels, not a rotating cast of models. Fifth, the pixel-clean measurement rail — every enquiry tagged to a service, a channel, a cost, and a stage — powered by Meta Catalyst IQ and Prism Pulse.
Where aesthetic marketing programmes usually stall is at move three or four. The paid engine gets built, the calendar gets shipped, and then reviews and doctor-led content lag by six months because they are the harder moves to force. ICG treats those two moves as first-quarter deliverables, not year-two ambitions.
The 4-pillar content framework
Every aesthetic-clinic content calendar we ship allocates posts across the four pillars below. Each pillar has a different job. Each moves a different KPI. The mix changes month-to-month based on what the last cycle's Prism Pulse data says the account actually needs.
| Pillar | What it is | Primary KPI it moves |
|---|---|---|
| Procedure Demystification | Injectable walk-throughs, laser session mechanics, downtime honesty, myth-busting Reels | Saves · Reach · Consult bookings |
| Doctor / Founder Voice | The clinician on camera — decisions, refusals, why a certain protocol is used, what the trend on Reels gets wrong | Follows · Brand searches · Trust |
| Result Documentation | Before-during-after content structured as process (never claim), with full consent and ASCI-safe framing | Enquiries · WhatsApp DMs |
| Clinic-as-Environment | Room walk-throughs, hygiene protocols, machine origins, staff introductions, aftercare touchpoints | Conversion assist · Reviews |
The pillar we see under-invested in most often is Doctor / Founder Voice. Owners lean on stock or influencer creative because it is faster to produce; then the account plateaus at cheap reach that does not convert to a consult. Every ICG engagement negotiates a founder-time commitment at contract stage — one hour a week on camera is the floor, and it is not optional.
Meta Catalyst IQ + Prism Pulse — the analytics stack behind every ICG aesthetic engagement
Aesthetic marketing without measurement is expensive theatre. Every ICG aesthetic account is instrumented from day one with two of our own products: Meta Catalyst IQ for the paid Meta Ads side and Prism Pulse for the organic Instagram side. Both were built inside ICG because horizontal reporting tools do not understand how a MedSpa's service lines map to creative decisions.
Meta Catalyst IQ ingests every ad-set, ad and creative across the clinic's Meta account, tags them to service lines the clinic actually sells, and returns a decision-ready view of which creatives are pulling cost-efficient consults versus which are pulling cheap reach that never becomes revenue. It powers the fortnightly creative kill-list — the ad sets we retire, the winners we scale, the new hooks we brief. Ad-set name drift, comparative alerts across creative sets, and the CPQL variance signal are the three signals we use most.
Prism Pulse does the same job for the organic Instagram engine. Deduplicated reach that matches the in-app number the founder sees, weekly period comparisons on views, saves and interactions, a service → KPI programming view that shows which specialty is pulling saves this month, and a shareable client report on a rotating URL that the marketing committee sees in 90 seconds. Between the two tools every rupee spent and every hour of production is accounted against a service line, a creative, and a stage of the funnel — the CPQL rail updates automatically.
The compliance triangle — CDSCO + ASCI + DPDP
Aesthetic marketing has a compliance triangle that is unlike the rest of healthcare. The three sides are the CDSCO device and drug rules, ASCI's advertising code, and the DPDP Act for consent architecture. Every asset that leaves an ICG account is filtered through all three before it goes live.
- CDSCO — the injectables, laser devices, energy-based platforms and the fillers most Indian MedSpas use are regulated as medical devices or drugs. Any claim that names a product (Botox, specific hyaluronic acid brands, specific laser platforms) has to sit inside the CDSCO-approved indications for that product. Off-label use is common in aesthetics, but publicly advertising it is not defensible. ICG's compliance scan flags brand-named claims and reframes them as procedure descriptions.
- ASCI's medical advertising code — before-and-after imagery is not banned, but it is heavily conditioned. Comparative superlatives ("best", "leading", "India's number one"), guaranteed outcomes, and testimonial-heavy content about a named consultant are the usual failure points. Aesthetic clinics get complaints more often than other specialties because their creative is easier to screenshot and their competitors are more organised about filing.
- DPDP Act 2023 — every enquiry form, every WhatsApp DM flow, every result-documentation asset needs an explicit consent architecture. Health data — and the CDSCO-classified devices most aesthetic clinics use put a lot of what you record into that bucket — carries a higher bar than the generic lead-gen setup. Retention limits, purpose limitation, and the takedown clause on patient content have to be codified before the campaign is live.
ICG's compliance filter is the first pass on every creative, not the last. If a Reel cannot be defended against a hypothetical ASCI complaint, it does not go into production. Founders sometimes push back on this — it feels like the safe creative loses reach. The three brands in our portfolio that took ASCI action in the last 24 months and had to rebuild their creative libraries under duress did not think it felt safe by month six.
What ICG delivers monthly
- Twelve to twenty organic posts per month across the four pillars, calibrated to specialty count and clinic cadence
- Six to twelve Reels per month, including at least two founder-led pieces and two documented-result pieces with full consent
- Daily Story cadence with polls, aftercare tips, behind-the-scenes, review reposts and consult booking prompts
- Meta Ads managed end-to-end via Meta Catalyst IQ — service-line-tagged creative, fortnightly kill-list, weekly CPQL report
- Compliance scan on every asset before publish — CDSCO device-and-drug frame · ASCI ad code · DPDP consent
- Monthly Prism Pulse dashboard access for the internal team plus a rotating shareable client report
- Google Business Profile management via Angryturtle — reviews, categories, photos, geo-grid rank tracking, publishing rights
- Monthly content strategy call with the account lead, a Prism Pulse-generated next-30-day calendar and a Meta Catalyst IQ creative brief for paid
- DM triage and WhatsApp routing so consult enquiries reach the front-desk without a manual forwarding chain
- Quarterly creative refresh and service-mix rebalance based on what Meta Catalyst IQ and Prism Pulse say the last 90 days actually did
Pricing tiers
ICG runs aesthetic-clinic engagements at three levels. The right tier depends on branch count, service-line depth, whether Meta Ads sits inside the retainer, and how much creative production the internal team is already handling. Every engagement begins with a Brand & Growth Diagnostic — quoted before we have seen the current footprint, the CRM state and the specialty priority, the tier is a guess that gets renegotiated in month two.
| Tier | Monthly investment | What it covers |
|---|---|---|
| Growth | ₹1,00,000 – ₹2,00,000 / month | Single-branch MedSpa or injectables clinic. 12 posts + 4 Reels + Prism Pulse + Meta Ads up to ₹2L/month spend on Meta Catalyst IQ + GBP via Angryturtle + monthly strategy call. |
| Scale | ₹2,50,000 – ₹4,50,000 / month | Multi-branch aesthetic group or full-stack MedSpa with lasers, injectables and body-contouring. 18–24 posts + 8–10 Reels + daily Stories + Meta Ads up to ₹6L/month on Meta Catalyst IQ + per-branch Prism Pulse reporting + fortnightly strategy call. |
| Enterprise | ₹5,00,000+ / month | Aesthetic chain (3+ branches, 6+ service lines) or dermatology-plus-aesthetic hybrid. 30+ posts + 12+ Reels + always-on Stories + Meta Ads managed at chain scale on Meta Catalyst IQ + branded per-branch Prism Pulse reports + weekly account rhythm + quarterly creative refresh. |
FAQs
How is an aesthetic-specialist agency different from a generalist digital agency that also takes aesthetic clients?
Three differences that show up on the invoice. First, the compliance triangle (CDSCO + ASCI + DPDP) is the first filter on creative, not the last. Second, service-line KPI mapping — a specialist knows injectables pull saves, laser hair reduction pulls enquiries, body contouring is a slow-burn brand play; a generalist reports the aggregate. Third, healthcare-native analytics — every ICG aesthetic account runs on Prism Pulse and Meta Catalyst IQ, both built inside ICG for this category.
How long before an aesthetic marketing programme produces meaningful movement?
Meta Ads consult-enquiry volume usually moves inside 30–45 days once service-line creative sets are live and Meta Catalyst IQ has run one kill-list cycle. Organic Instagram enquiry lift compounds between month three and month six as Doctor Voice and Result Documentation build a library. GBP-driven Maps consult volume lifts on the longer clock, six to nine months.
Do you handle Meta Ads inside the retainer, or is it a separate line?
Meta Ads is handled end-to-end via Meta Catalyst IQ inside the retainer at Scale and Enterprise. Growth-tier clinics can bolt it on, or start organic-only and layer Meta Ads once the converting creative is proven. The media budget sits outside the retainer, billed on actual spend, with a fortnightly Meta Catalyst IQ CPQL report.
Can you promise a specific CPQL for injectables or laser hair reduction?
No. The CPQL benchmark for aesthetic dermatology sits around ₹290 across our portfolio on a rolling 12-month window, but the number for any single clinic is a function of city, service mix, ticket size and current creative library. Any agency quoting a locked CPQL before a diagnostic is either invoicing against a made-up number or absorbing the delta from margin.
Do you work with international aesthetic groups, or India only?
India only. Every ICG aesthetic engagement is compliance-scoped to CDSCO, ASCI and DPDP. Brands targeting US or UK aesthetic buyers need a different compliance frame (FDA / MHRA / FTC) and a rebuilt creative library — not a scope we run.
Can we white-label Prism Pulse and Meta Catalyst IQ reports for internal management review?
Yes. Both workspaces support the clinic or group's own logo, colour and footer on the shareable report layer. The management committee sees the brand's report, not ICG's.
